Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

As the pharmaceutical industry continues to evolve, aseptic processing must keep pace with advancing technologies. The choice between Open RABS, Closed RABS, and Isolators is crucial in ensuring sterility, regulatory compliance, and cost-effectiveness in injectable manufacturing.
Annex 1 is part of the European Good Manufacturing Practice (EU GMP) guidelines, specifically addressing the production of sterile pharmaceutical products. Companies manufacturing injectables, ophthalmic solutions, sterile powders, and other sterile dosage forms must comply with these regulations to meet
FDA drug recalls play a critical role in protecting public health by ensuring that unsafe or defective products are removed from the market. Staying ahead of compliance challengesFDA recalls are costly, but proactive compliance measures can significantly reduce the risks.
As single-use technologies gain traction in aseptic manufacturing, they’re transforming production flexibility, cost-efficiency, and contamination risk management. Learn why these systems are becoming the industry standard.
As the demand for affordable, effective treatments grows, biosimilars offer promising solutions in healthcare. Explore the potential, challenges, and regulatory landscape shaping this expanding market
A robust contamination control strategy is vital in regulated industries to maintain safety and compliance. Discover key components, documentation practices, and best strategies to reduce contamination risks.
Explore the essential distinctions that exist between the previous version and the most recent updates of the EU GMP Annex 1 guidelines. Understand how these changes play a critical role in shaping the practices of sterile pharmaceutical manufacturing. Additionally, examine
Good distribution practices ensure maintaining product safety and quality during distribution across the supply chain and this practice is of significant importance for the pharmaceutical industry. Good Distribution Practices (GDP) Compliance report for Pharmaceutical Industry demonstrates Quality commitment & sound
The qualification of a GMP facility is essential to ensure the high standards of pharmaceutical production and to guarantee product quality. In our latest article, you will learn the 10 most important steps for the successful qualification of a new
Pharmacopoeias are essential references that ensure the quality, safety, and efficacy of medicines worldwide. They harmonize drug standards across different regions, ensuring consistent criteria for purity and potency.